Which industrial sectors are thriving in Australia and New Zealand and are seen as offering significant investment opportunities by GTAI?
Stumpf: Both Australia and New Zealand have a very good research environment, which has spurred the development of innovative medical-technology companies. Germany, the largest European healthcare market, offers them many opportunities. Companies like Cochlear (Australia), Resmed (Australia) or Fischer & Paykel (New Zealand) are already active in Germany. The IT sector is also booming. Australia also has a thriving start-up scene with some 1,500 companies evolving around numerous supporting institutions, such as the Sydney Startup Hub. These hubs are focused on important areas, including artificial intelligence, agricultural technology and FinTech. Morevoer, New Zealand’s technology sector is booming: the country’s 200 largest tech companies increased their sales by 11 percent between 2017 and 2018.
GTAI works closely with the AHK in Sydney. How does this cooperation benefit investors?
Stumpf: GTAI and AHK share information, and their services complement each other well. For example, local companies interested in the German market can take advantage of delegation trips or a business partner placement organized by AHK. Meanwhile, if a concrete opportunity arises in Germany, GTAI can help with finding a location and provide information about possible subsidies.